Femara® 2,5 mg NOVARTIS

54,00 541,52 

SKU: N/A Category:

Description

Contraindications to use

Hypersensitivity to letrozole; endocrine disorders characteristic of the premenopausal period; pregnancy, lactation; children under 18 years of age.

Caution: severe hepatic insufficiency (Child-Pugh class C), severe renal insufficiency (CK<10 ml/min), concomitant use with potent inhibitors of CYP3A4 and CYP2A6 isoenzymes. Concomitant use with drugs with a narrow therapeutic index whose excretion depends mainly on the CYP2C19 isoenzyme.

Use during pregnancy and lactation

Use is contraindicated during pregnancy and lactation.

Use in hepatic impairment

Caution should be exercised in patients with severe hepatic insufficiency (Child-Pugh class C).

Use in renal impairment

Caution should be exercised in patients with severe renal impairment (creatinine clearance < 10 ml/min). The ratio of the expected therapeutic effect to the possible risks of treatment should be carefully considered.

Additional information

substance active

letrozole

Amount of substance, mg

2.5

formulaire de discharge

compressed

1 compressed, mg

2.5

Plaquettes thermoformed by package, pieces

dix

manufacturer

NOVARTIS Pharma GmbH

volume de commande

1 blister of 10 compresses, 1 pack (3 blisters), 1 package (10 blisters)

Reviews

There are no reviews yet.

Be the first to review “Femara® 2,5 mg NOVARTIS”

Your email address will not be published. Required fields are marked *

Select options This product has multiple variants. The options may be chosen on the product page